Search - tctmd.com

Displaying 201 - 220 of 224

Sort: Relevancy | Date

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation Fellows 2014

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish Parikh

April 13, 2014

Presentation

Emboline - Aortic Embolic Protection Solutions

Presenter: Amir Belson

December 02, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation TCT 2013

Predictors Of Carotid Clamping Intolerance During Carotid Artery Stenting With Proximal Embolic Protection Device. Results From An Italian Registry.

Presenter: Giuseppe Giugliano

October 29, 2013

Presentation TCT 2013

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Davide Capodanno

October 27, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Presenter: L. Bijuklic

June 06, 2013

Presentation Fellows 2013

Thrombectomy and Embolic Protection Systems

Presenter: Manish Parikh

April 16, 2013

Presentation TCT 2013

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

Presentation TCT 2012

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Presenter: Martyn Thomas

October 25, 2012

Presentation TCT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Presenter: Klaudija Bijuklic

October 23, 2012

Presentation TCT 2012

Debate II. Should Embolic Protection Be Mandatory in Lower Extremity Intervention? - Con!

Presenter: Mark Burket

October 22, 2012

Presentation TCT 2012

Debate II. Should Embolic Protection Be Mandatory in Lower Extremity Intervention? - Pro!

Presenter: D. Christopher Metzger

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Presenter: Michel Henry

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Presenter: Christopher Cooper

October 22, 2012

Presentation ACVS 2012

Embolic Protection Devices: Review of Available Devices and Evidence for Use

Presenter: Manish Parikh

August 04, 2012

Advertisement

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Emboline - Aortic Embolic Protection Solutions

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Predictors Of Carotid Clamping Intolerance During Carotid Artery Stenting With Proximal Embolic Protection Device. Results From An Italian Registry.

Atherotomy, Atherectomy, and Embolic Protection

Cerebral Embolic Protection Devices

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Thrombectomy and Embolic Protection Systems

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Cerebral Embolic Protection during TAVR: Metrics for Evaluating Safety and Efficacy

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

TCT-1. Risk Factors for Cerebral Embolization After Carotid Artery Stenting with Embolic Protection – A DW–MRI Study in 827 Patients

Debate II. Should Embolic Protection Be Mandatory in Lower Extremity Intervention? - Con!

Debate II. Should Embolic Protection Be Mandatory in Lower Extremity Intervention? - Pro!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Embolic Protection Devices: Review of Available Devices and Evidence for Use

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content